The global pandemic is impacting supply chains worldwide, but pharmaceutical supply chains are especially vulnerable. Manufacturers are under pressure to help maintain the supply of critical medicines during COVID-19 as well as contribute to the on-going efforts to support the ever-changing supply chain.
As pharmaceutical manufacturers reprioritize production due to changing and increased product demand, many don’t have alternate suppliers for critical components. This has been a game-changer as they not only have to identify new suppliers, but they must also qualify these components to ensure they understand impact on process, and that quality meets the required standards.
Manufacturing partners across geographic regions are navigating this “new normal” under stressful conditions exacerbated by increased demand for APIs, new supply chain challenges, and an ever-increasing global focus on maintaining quality. To truly succeed as an industry, we must knowledge share and problem-solve together to advance and proactively prepare for the continued success of our mission as an industry.
As Co-Chairs of the 2020 ISPE Asia Pacific Pharma Manufacturing Virtual Conference & Executive Forum, we invite you to join us for this collaborative forum where you can learn and ask questions on key trends, best practices, and regulatory perspectives for maintaining pharma supply chain reliance, overall quality, and compliance sustainability.
Nowhere else can you participate in actionable, interactive discussions featuring case studies and dedicated Q&A time with experts representing FDA, MHRA, local health authorities, Pfizer, Biocon, and more as they answer questions like:
You can submit your questions on the event homepage prior to the conference or ask your questions in real-time. Stay knowledgeable throughout the year with on demand access to all session recordings and presentations for one year.
Collaboration is a crucial element in mitigating the impact of COVID-19 on the pharmaceutical supply chain. We encourage you to register today to ensure you have the strategies to make your operations more agile, compliant, and resilient to disruption.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...